Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (11-20 of 280) with videos related to

Pageof 28
Sort By:
Journal of the National Cancer Institute. Monographs|June 16, 2011
Biobanking in a fast moving world: an international perspectiveRobert Hewitt, Pierre Hainaut
Current Opinion in Oncology|November 15, 2012
Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapyPierre Hainaut, Amelie Plymoth
Acta Biochimica Polonica|April 4, 2003
TP53 and mutations in human cancerKatarzyna Szymańska, Pierre Hainaut
Current Opinion in Oncology|December 7, 2011
Cancer as a metabolic diseasePierre Hainaut, Amelie Plymoth
Biomarkers in Medicine|December 8, 2010
Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicineKurt Zatloukal, Pierre Hainaut
Lancet (London, England)|February 5, 2008
Curbing the liver cancer epidemic in AfricaPierre Hainaut, Peter Boyle
The Journal of Pathology|November 18, 2009
Massively regulated genes: the example of TP53Monica Hollstein, Pierre Hainaut
Oncogene|April 13, 2005
Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activitySéverine Seemann, Pierre Hainaut
Current Opinion in Oncology|January 22, 2021
Editorial: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2), COVID-19 and cancer: three research questions casting a long shadowPierre Hainaut, Paolo Boffetta
Antioxidants & Redox Signaling|January 4, 2011
Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescenceHind Hafsi, Pierre Hainaut
Pageof 28

Showing results (11-20 of 280) with videos related to

Sort By:
Pageof 28
Journal of the National Cancer Institute. Monographs|June 16, 2011
Biobanking in a fast moving world: an international perspectiveRobert Hewitt, Pierre Hainaut
Current Opinion in Oncology|November 15, 2012
Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapyPierre Hainaut, Amelie Plymoth
Acta Biochimica Polonica|April 4, 2003
TP53 and mutations in human cancerKatarzyna Szymańska, Pierre Hainaut
Current Opinion in Oncology|December 7, 2011
Cancer as a metabolic diseasePierre Hainaut, Amelie Plymoth
Biomarkers in Medicine|December 8, 2010
Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicineKurt Zatloukal, Pierre Hainaut
Lancet (London, England)|February 5, 2008
Curbing the liver cancer epidemic in AfricaPierre Hainaut, Peter Boyle
The Journal of Pathology|November 18, 2009
Massively regulated genes: the example of TP53Monica Hollstein, Pierre Hainaut
Oncogene|April 13, 2005
Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activitySéverine Seemann, Pierre Hainaut
Current Opinion in Oncology|January 22, 2021
Editorial: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2), COVID-19 and cancer: three research questions casting a long shadowPierre Hainaut, Paolo Boffetta
Antioxidants & Redox Signaling|January 4, 2011
Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescenceHind Hafsi, Pierre Hainaut
Pageof 28